Keyphrases
Testosterone
100%
Observational Cohort Study
100%
Testosterone Undecanoate
100%
Young Patients
40%
Elderly Patients
40%
Hematocrit
40%
Targeted Treatment
30%
Polycythemia
30%
Age-adjusted
20%
Serum Testosterone
20%
Non-associated
10%
Treatment Regimen
10%
Follow-up Time
10%
Time-to-treatment
10%
Age Groups
10%
Treatment Risk
10%
Pharmacokinetics
10%
Single Center
10%
Adjusted Means
10%
Adverse Outcomes
10%
Testosterone Replacement Therapy
10%
Free Testosterone
10%
Intramuscular Injection
10%
Longitudinal Observational Study
10%
Testosterone Deficiency
10%
Medicine and Dentistry
Cohort Study
100%
Testosterone Undecanoate
100%
Elderly Patient
40%
Hematocrit
40%
Polycythemia vera
30%
Symptom
10%
Observational Study
10%
Population Research
10%
Adverse Outcome
10%
Androgen Therapy
10%
Testosterone
10%
Pharmacokinetics
10%
Intramuscular Injection
10%
Androgen Deficiency
10%
Nursing and Health Professions
Cohort Analysis
100%
Testosterone Undecanoate
100%
Elderly Patient
40%
Hematocrit
40%
Polycythemia vera
30%
Testosterone Blood Level
20%
Symptom
10%
Androgen Deficiency
10%
Adverse Outcome
10%
Intramuscular Drug Administration
10%
Testosterone
10%
Androgen Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Testosterone Undecanoate
100%
Polycythemia vera
30%
Population Study
10%
Observational Study
10%
Symptom
10%
Pharmacokinetics
10%
Adverse Outcome
10%
Testosterone
10%
Intramuscular Injection
10%
Androgen Deficiency
10%
Agricultural and Biological Sciences
Cohort Studies
100%
Testosterone Undecanoate
100%
Hematocrit
40%
Observational Studies
10%
Pharmacokinetics
10%
Androgen Deficiency
10%
Intramuscular Injection
10%
Neuroscience
Testosterone Undecanoate
100%
Hematocrit
40%
Pharmacokinetics
10%
Testosterone
10%